Sorrento Therapeutics, Inc. (NASDAQ:SRNE) announced it's exploring the possibility of an initial public offering of its majority-owned subsidiary, Scilex Holding.
Scilex Holding is a pharmaceutical company that delivers pain management products.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
No decisions have been made at this point on the structure or timing of the possible IPO, and no assurance can be given that an IPO will be pursued or completed.
Sorrento's stock closed Tuesday at $2.99 per share.